Lactic Acid in Tumour Biology

Authors: Ignasi Barba i Cristina Cruz.

Funding: This research received no external funding.

DOI: https://doi.org/10.3390/metabo16010075

Keywords: cancer, tumour microenvironment, lactic acid, lactate, Warburg effect, immune function.

Read More

Lactic acid accumulates in the tumour microenvironment (TME) at concentrations reaching up to 40 mM. Initially, lactic acid was considered merely a metabolic by-product of aerobic glycolysis, a phenomenon commonly referred to as the Warburg effect and observed in the majority of tumours. Recent evidence, however, has demonstrated that lactic acid is not merely a waste product; rather, it plays a pivotal role in tumour biology. High plasma lactic acid levels correlate with increased metastatic potential and lower survival rates. Elevated lactic acid levels in the TME have been shown to suppress antitumour immune responses, facilitate both metastasis and cellular senescence, and might modulate gene expression through novel epigenetic mechanisms such as histone lactylation. This review aims to summarize current knowledge on the multifaceted impact of elevated lactic acid in the TME on tumour progression and biology.

Once regarded merely as a metabolic waste product, lactate is now recognized as a central player in cancer biology. Tumour cells can exploit lactate as an efficient energy source via mitochondrial oxidative phosphorylation (OXPHOS) and can induce stromal cells to enhance its production, fostering a metabolically supportive microenvironment. Beyond its metabolic role, lactic acid functions as a signalling molecule—acting through receptors such as GPR81 or via direct protein lactylation—to drive immunosuppression, promote metastasis, and modulate diverse aspects of tumour progression.
Therapeutic strategies aimed at reducing lactate abundance or its downstream effects in the TME are gaining traction. Approaches include inhibiting lactate production, disrupting its transport, or targeting lactate-mediated signalling pathways. In parallel, lactate is being investigated as a prognostic biomarker and a potential indicator of treatment response, offering both mechanistic insights and clinical utility in oncology.

Leave A Comment

Go to Top